BioMark has recently completed a very encouraging metabolome study that has implication for biomarker signature related to cancer diagnosis. The discovery is being patented.
Elisa Kit Development – BioMark has successfully developed Elisa kits using antibodies generated at UBC’s Biomedical Research Centre by Dr. Schrader and his team. The kits were developed under CLSI specifications and are under key customer test site. Double blinded study was also designed to ensure the reliability of the test kits Point Of Care […]